These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37417658)

  • 21. Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective.
    Ahmed FZ; Taylor JK; John AV; Khan MA; Zaidi AM; Mamas MA; Motwani M; Cunnington C
    ESC Heart Fail; 2021 Oct; 8(5):3906-3916. PubMed ID: 34382749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
    Palazzuoli A; Testani JM; Ruocco G; Pellegrini M; Ronco C; Nuti R
    Int J Cardiol; 2016 Dec; 224():213-219. PubMed ID: 27657476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic.
    Vaishnav J; Hubbard A; Chasler JE; Lepley D; Cuomo K; Riley S; Menzel K; Fajardo J; Sharma K; Judge DP; Russell SD; Gilotra NA
    Am Heart J; 2021 Mar; 233():122-131. PubMed ID: 33352187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.
    Wierda E; Dickhoff C; Handoko ML; Oosterom L; Kok WE; de Rover Y; de Mol BAJM; van Heerebeek L; Schroeder-Tanka JM
    ESC Heart Fail; 2020 Jun; 7(3):892-902. PubMed ID: 32159279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Door-to-furosemide time and clinical outcomes in acute heart failure.
    Marques P; Brito MT; Vasques-Nóvoa F; Ferreira JP; Jardim AL; Gouveia R; Besteiro B; Vieira JT; Gomes F; Leite-Moreira A; Bettencourt P; Almeida J; Friões F
    Eur J Emerg Med; 2023 Apr; 30(2):85-90. PubMed ID: 36735452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
    BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
    Frea S; Pidello S; Volpe A; Canavosio FG; Galluzzo A; Bovolo V; Camarda A; Golzio PG; D'Ascenzo F; Bergerone S; Rinaldi M; Gaita F
    Clin Res Cardiol; 2020 Apr; 109(4):417-425. PubMed ID: 31256261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
    Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
    J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure.
    Testani JM; Brisco MA; Turner JM; Spatz ES; Bellumkonda L; Parikh CR; Tang WH
    Circ Heart Fail; 2014 Mar; 7(2):261-70. PubMed ID: 24379278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Effect of the Dose of Loop Diuretic Over 5 Years in Chronic Heart Failure.
    Laszczyńska O; Severo M; Friões F; Lourenço P; Silva S; Bettencourt P; Lunet N; Azevedo A
    J Card Fail; 2017 Aug; 23(8):589-593. PubMed ID: 28390907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambulatory Intravenous Diuretic Clinic Associated with Short-Term Risk Reduction in Mortality and Rehospitalizations in Patients Discharged with Heart Failure.
    St Amand A; Taveira TH; Henthorne KE; Wu WC
    R I Med J (2013); 2020 Nov; 103(9):16-21. PubMed ID: 33126781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IV Diuresis in Alternative Treatment Settings for the Management of Heart Failure: Implications for Mortality, Hospitalizations and Cost.
    Jiang GY; Lee C; Kearing SA; Wadhera RK; Gavin MC; Wasfy JH; Zeitler EP
    J Card Fail; 2024 Jan; 30(1):4-11. PubMed ID: 37714260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.
    Palazzuoli A; Pellegrini M; Franci B; Beltrami M; Ruocco G; Gonnelli S; Angelini GD; Nuti R
    Intern Emerg Med; 2015 Feb; 10(1):41-9. PubMed ID: 25087085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions.
    Ferreira Reis J; Valentim Gonçalves A; Ilhão Moreira R; Pereira da Silva T; Timóteo AT; Pombo D; Carvalho T; Correia C; Santos C; Cruz Ferreira R
    Rev Port Cardiol; 2023 Apr; 42(4):335-343. PubMed ID: 36634758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients.
    Cunha FM; Pereira J; Marques P; Ribeiro A; Bettencourt P; Lourenço P
    J Cardiovasc Med (Hagerstown); 2020 Jan; 21(1):21-26. PubMed ID: 31714331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diuretic response in acute heart failure-an analysis from ASCEND-HF.
    ter Maaten JM; Dunning AM; Valente MA; Damman K; Ezekowitz JA; Califf RM; Starling RC; van der Meer P; O'Connor CM; Schulte PJ; Testani JM; Hernandez AF; Tang WH; Voors AA
    Am Heart J; 2015 Aug; 170(2):313-21. PubMed ID: 26299229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.